Arkolith/Insider Trading/RANI/Form 4

Imran Talat

Chief Executive Officer, DirectorRani Therapeutics Holdings, Inc. (RANI) · full profile →Form 4 · filed Dec 7, 2023
Net Buying
Open-Market Buys
$23K
Open-Market Sells
$0
Net Open-Market Flow
$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 6, 2023Buy(P)10K$2.27$23K484K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-068864) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML